Close

Salesforce (CRM) Shares Plunge on Weaker Profit Guidance, Bull Thesis Remains Intact Says Analyst

Go back to Salesforce (CRM) Shares Plunge on Weaker Profit Guidance, Bull Thesis Remains Intact Says Analyst

salesforce.com (CRM) PT Lowered to $315 at UBS

December 1, 2021 5:02 AM EST

UBS analyst Karl Keirstead lowered the price target on salesforce.com (NYSE: CRM) to $315.00 (from $330.00) while maintaining a Buy rating.... More

salesforce.com (CRM) PT Raised to $370 at Goldman Sachs

December 1, 2021 3:26 AM EST

Goldman Sachs analyst Kash Rangan raised the price target on salesforce.com (NYSE: CRM) to $370.00 (from $360.00) while maintaining a Conviction Buy rating.... More

Salesforce (CRM) Tops Q3 EPS by 35c, Offers Q4 Guidance

November 30, 2021 4:06 PM EST

Salesforce (NYSE: CRM) reported Q3 EPS of $1.27, $0.35 better than the analyst estimate of $0.92. Revenue for the quarter came in at $6.86 billion versus the consensus estimate of $6.79 billion.

GUIDANCE:

Salesforce sees Q4 2022 EPS of $0.72-$0.73, versus the consensus of $0.81. Salesforce sees Q4 2022... More